African Americans With RCC Maintain Inferior Survival in Targeted Therapy Era
Various genomic differences in African American patients with clear cell renal cell carcinoma predict for reduced responsiveness.
Various genomic differences in African American patients with clear cell renal cell carcinoma predict for reduced responsiveness.
Renal cell carcinoma samples with higher entropy, a measure of evenness and diversity, were associated with favorable prognosis.
A steady overall survival and objective response rate benefit with nivolumab vs everolimus was observed across baseline factors.
Risk score that can accurately predict the presence of adherent perinephric fat (APF) in patients with small renal masses.
A study presented at the Genitourinary Cancers Symposium evaluated two different fractionation schedules suitable for low-risk prostate cancer.
A recent study examined the efficacy of differing high-dose IMRT schedules on prostate cancer treatment.
Anti-androgen therapy during and after salvage radiotherapy in patients with localized prostate cancer significantly improved long-term overall survival.
The addition of zoledronic acid and celecoxib increases survival for men with hormone therapy-naïve metastatic prostate cancer.
Survival in stage IV breast cancer is improving, notably so in some patients treated initially with surgery.